Viewing Study NCT04361032


Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2025-12-25 @ 7:27 PM
Study NCT ID: NCT04361032
Status: UNKNOWN
Last Update Posted: 2020-08-27
First Post: 2020-04-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia
Sponsor: Abderrahmane Mami Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-09-04
Start Date Type: ESTIMATED
Primary Completion Date: 2020-09-04
Primary Completion Date Type: ESTIMATED
Completion Date: 2020-10-04
Completion Date Type: ESTIMATED
First Submit Date: 2020-04-22
First Submit QC Date: None
Study First Post Date: 2020-04-24
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-08-26
Last Update Post Date: 2020-08-27
Last Update Post Date Type: ACTUAL